Abstract:In the past decades, the treatment methods for tumors have been changing rapidly. Traditional treatment methods, such as radiotherapy and chemotherapy regimens, have gradually revealed their shortcomings. As scientists continue to study the tumor microenvironment, new cellular properties, and immune checkpoints regarding TME are being discovered, and immunotherapy based on monoclonal antibodies, engineered cells, tumor vaccines, and other technologies have shown good therapeutic effects and lower risks. This review presents the latest research about TME and the latest progress in immunotherapy. Cancer is now considered a tumor microenvironment (TME) disease, although it was originally thought to be a cell and gene expression disorder. Over the past 20 years, significant advances have been made in understanding the complexity of the TME and its impact on responses to various anticancer therapies, including immunotherapies. Cancer immunotherapy can recognize and kill cancer cells by regulating the body's immune system. It has achieved good therapeutic effects in various solid tumors and hematological malignancies. Recently, blocking of programmed death‐1 (PD‐1), programmed death‐1 ligand‐1 (PD‐L1), and programmed death Ligand‐2 (PD‐L2), the construction of antigen chimeric T cells (CAR‐T) and tumor vaccines have become popular immunotherapies Tumorigenesis, progression, and metastasis are closely related to TME. Therefore, we review the characteristics of various cells and molecules in the TME, the interaction between PD‐1 and TME, and promising cancer immunotherapy therapeutics.

Potential Strategies to Improve the Effectiveness of Drug Therapy by Changing Factors Related to Tumor Microenvironment

Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies

Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment

Tumor Microenvironment‐Enabled Nanotherapy

Nanoparticles for Modulating Tumor Microenvironment to Improve Drug Delivery and Tumor Therapy

Drug resistance and tumor immune microenvironment: An overview of current understandings (Review)

The tumor microenvironment: a key player in multidrug resistance in cancer

Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy

Nanotherapy Targeting the Tumor Microenvironment

Underlying mechanisms and drug intervention strategies for the tumour microenvironment

The updated landscape of tumor microenvironment and drug repurposing

Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.

Overcoming the Biological Barriers in the Tumor Microenvironment for Improving Drug Delivery and Efficacy

Enhancing the Treating Efficacy of Immunotherapy Through the Restructure of Tumor Microenvironment

The tumor microenvironment: shaping cancer progression and treatment response

Advances in targeting tumor microenvironment for immunotherapy

Role of tumor microenvironment in cancer progression and therapeutic strategy

Tumor microenvironment as a complex milieu driving cancer progression: a mini review

Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics

Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement

Tumor Therapy Strategies Based on Microenvironment‐Specific Responsive Nanomaterials